Oocyte Vitrification Aided With Latrunculin A

Ibn Sina Hospital

Status: Completed

Conditions: Infertility

Treatments: Other: Latrunculin A supplemented vitrification medium

Study type: Interventional

Funder types: Other

Identifiers

NCT03678571

IbnSina-Oocyte-LA

Details and patient eligibility

About

Using cytoskeleton Stabilizer the Latrunculin A would improve the outcome of oocyte vitrification

Enrollment: 400 patients

Sex: Female

Ages: 18 to 42 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• indication for oocyte cryopreservation

Exclusion criteria

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

400 participants in 2 patient groups

Latrunculin A supplemented vitrification medium

Experimental group

Treatment:

Other: Latrunculin A supplemented vitrification medium

Vitrification medium with no supplementation

No Intervention group